Purchase Order 36C25624P1388

Award Date 7/26/24
Potential Completion Date 10/31/24
Potential Value $145K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration awarded a $150,176.00 firm fixed price purchase order contract to Illumina, Inc. to provide Infinium MethylationEPIC and Multi-Ethnic Global genotyping and epigenetic analysis kits based on bead array technology. These kits enable highly multiplexed measurement of DNA methylation at individual CpG loci across the human genome. The contract has no set-aside designation. Through past prime federal awards, Illumina has supplied a...
This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $76,993.80 contract is for the provision of Infinium Methylation EPIC supplies and accessories, with no set-aside designation. Illumina has previously held prime federal contracts and subcontracts with agencies such as the NIH, CDC, USDA, and VA to provide a range of genomic sequencing...
This is a firm fixed price purchase order awarded by the Veterans Integrated Service Network 16 of the Department of Veterans Affairs to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract, valued at $115,817.23, is for the provision of INFINIUM METHYLATION EPIC SAMPLES, which are likely related to genomic sequencing and analysis services. The contract has no set-aside designation and is not associated with a larger indefinite delivery...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 awarded a $103,512 firm fixed price delivery order to Illumina, Inc. for preventative maintenance and repair services for Illumina sequencing equipment. The one-year contract period runs from June 1, 2022 through May 31, 2023 to support the agency's genomics programs. No set-aside provisions were applied to this award made under an existing vehicle. The place of performance is in Little Rock,...
This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) to Illumina, Inc. for the provision of microarray kits. The contract has a ceiling value of $997,972.18 and does not have a set-aside designation. Illumina, a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, has previously received prime federal contracts and subcontracts from agencies such as the National Institutes of Health (NIH), Centers for Disease...
The Department of Veterans Affairs (VA) awarded a $272,276.80 firm fixed-price delivery order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of microarray kits, with a performance period ending on February 6, 2020. Illumina has a history of providing sequencing systems, reagents, and services to support genomic research and diagnostics across various federal agencies, including the NIH, CDC,...
The Department of Veterans Affairs (VA) awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract, valued at $274,063.35, is for the provision of proprietary DNA testing kits, including the Multi-Ethnic Global, EPIC, and PsychArray Kits, to support the VA's genetic analysis and research requirements. The contract does not have a set-aside designation. Illumina has previously provided sequencing...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 awarded a $107,704.56 firm fixed price delivery order to Illumina, Inc. for preventative maintenance and repair services of Illumina sequencing equipment. The one-year contract supports VISN 16's genomics programs and has a period of performance through May 31, 2024. No set-aside provisions were applied to this award to the prime contractor Illumina for continued equipment upkeep at its...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and analytical solutions. The $75,741.60 contract is for the provision of Illumina's INFINIUM METHYLATION EPIC 96 SAMPLES system and associated services, to be performed in San Diego, California. The award does not have any set-aside designation. Illumina has a history of providing genomic sequencing systems and reagents to support...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order contract worth $344,084.80 to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. This order is not part of a set-aside program. Illumina will provide microarray kits to support genomic sequencing and analysis for research and diagnostics purposes at the agency. Illumina has previously provided a range of sequencing instruments,...

The Department of Veterans Affairs (VA), Veterans Health Administration (VHA), Network Contracting Office (NCO) 16 awarded a $145,315.10 firm fixed-price purchase order contract to Illumina, Inc. to provide Infinium MethylationEPIC V2.0 BeadChip Kits for use with the Illumina iScan and Autoloader 2 system in the Pharmacogenomics Analysis Laboratory at the John L. McClellan VA Hospital in Little Rock, AR. This sole-source contract was awarded under the authority of FAR 6.302-1, as the VA determined Illumina is the only vendor capable of providing the required items. The contract has an ultimate completion date of October 31, 2024 and does not contain a set-aside designation. Illumina, a manufacturer of sequencing and array-based genomic analysis solutions, has previously provided a range of products and services to support genomic research and diagnostics across various federal agencies.

Generated 9/7/24, 9:39 AM